Bragar Eagel & Squire, P.C. Reminds Investors That Class

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
34
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Aphria, NVIDIA, DXC Technology, and Immunomedics and Encourages Investors to Contact the Firm

NEW YORK, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Aphria Inc., NVIDIA Corporation, DXC Technology Company, and Immunomedics, Inc.  Stockholders have until the deadlines listed below to petition the court to serve as lead plaintiff.  Additional information about each case can be found at the link provided.

Aphria Inc. (NYSE: APHA)

Class Period: July 17, 2018 - December 4, 2018

Lead Plaintiff Deadline: February 4, 2019

The complaint alleges that throughout the class period defendants made materially false and misleading statements and failed to disclose to investors: (i) that Latin American assets acquired by the company lacked adequate licenses to operate and were overvalued; and (ii) that the acquisition of Latin American assets would enrich the company’s CEO and other insiders at the expense of shareholders.  The complaint further alleges that, as a result of the foregoing, investors purchased Aphria’s securities at artificially inflated prices during the Class Period and suffered investment losses as a result of defendants’ conduct.

To learn more about the Aphria class action go to: http://bespc.com/apha / .

NVIDIA Corporation (NASDAQ: NVDA)

Class Period: August 10, 2017 - November 15, 2018

Lead Plaintiff Deadline: February 19, 2019

The complaint alleges that throughout the class period defendants assured investors that the company followed the market closely and could adjust to rapid changes in the cryptocurrency markets.  Even as analysts increasingly began to question the company’s ability to manage inventory in the face of an uncertain cryptocurrency market, defendants touted that NVIDIA and its executives are “masters at managing our channel, and we understand the channel very well.”  NVIDIA also repeatedly assured investors that surging demand for Graphics Processing Units (“GPUs”) among cryptocurrency miners would not have a negative impact on the company because of strong demand for GPUs by NVIDIA’s core customer base of computer gamers. 

To learn more about the NVIDIA class action go to: http://bespc.com/nvda/ .

DXC Technology Company (NYSE: DXC)

Class Period: February 8, 2018 - November 6, 2018

Lead Plaintiff Deadline: February 25, 2019

The complaint alleges that throughout the class period defendants made false and misleading statements and/or failed to disclose adverse information regarding the company’s business and prospects.  Specifically, defendants failed to disclose that the company had changed or planned to change the operations of its sales teams, deploying generalized sales teams as opposed to the specialized teams that were better capable of delivering specialized services to its clients; that the company’s workforce optimization strategy of sharply reducing staff while reducing costs was resulting in a shortage of sales personnel who could execute on demand for services, thereby risking and ultimately losing sales and revenue opportunities; and that, as a consequence, the company’s revenue and financial performance guidance for fiscal 2019 was without a reasonable basis.

To learn more about the DXC class action go to: http://bespc.com/dxc/ .

Immunomedics, Inc. (NASDAQ: IMMU)

Class Period: August 23, 2018 - December 20, 2018

Lead Plaintiff Deadline: February 25, 2019

The complaint alleges that throughout the class period defendants made false and/or misleading statements, as well as failed to disclose material adverse facts.  On December 17, 2018, FDAnews.com published an article titled “FDA Hits Immunomedics for Data Integrity Breach.” According to this article, “[t]he FDA cited Immunomedics for a host of violations - including its handling of a data integrity breach - observed at its Morris Plains, New Jersey, drug substance manufacturing facility between August 6 and 14.”  The article states that this breach included “manipulated bioburden samples, misrepresentation of an integrity test procedure in the batch record, and backdating of batch records, such as dates of analytical results.”

To learn more about the Immunomedics class action go to: http://bespc.com/immu / .

Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation.  For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com .  Attorney advertising.  Prior results do not guarantee similar outcomes. 

Contacts Bragar Eagel & Squire, P.C. Brandon Walker, Esq. Melissa Fortunato, Esq. (212) 355-4648 investigations@bespc.com www.bespc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 183

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 210

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 128

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 217

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 154

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 187

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 187

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 238

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 169

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 302

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

Kipu Health Strengthens Behavioral Health with Hatch Compliance Deal

Updated Category News Views 184

Kipu Health Expands Its Portfolio with a Strategic Acquisition Kipu Health is making a significant advancement in the behavioral health sector by acquiring Hatch Compliance. This merger brings in cutting-edge compliance management systems specifically designed for behavioral health organizations. Boosting Operational Efficiency for Behavioral Health Organizations As a...

Continue Reading
Exploring the Future of Autonomous Economy with Lav and Magma

Updated Category News Views 245

Understanding the Autonomous Economy Lava Network and Magma Devs, in collaboration with Google Cloud, are set to delve into the transformative concept of the autonomous economy. This ambitious initiative aims to showcase how artificial intelligence (AI) agents and stablecoins are revolutionizing digital commerce. The exciting event will bring together industry leaders to...

Continue Reading
Micross Expands with AEMtec Acquisition: European Growth

Updated Category News Views 68

Micross Advances into Europe with AEMtec Acquisition Here's the scoop: Micross Components, a heavyweight in microelectronics, just sealed a deal to acquire AEMtec GmbH. This acquisition isn't just peanuts—it's a big leap forward for Micross, broadening its European presence and bolstering its advanced packaging and optoelectronics game. You'd think these folks mean...

Continue Reading
Innovative Vanpool Program Revolutionizes Student Transportation

Updated Category News Views 128

Transforming Student Transportation with Vanpool Systems Augusta County Public Schools has taken a significant step in improving student transportation through an innovative vanpool program. Collaborating with Secure Solar Futures, this program focuses on utilizing plug-in electric vans, greatly enhancing the transportation experience for students. How the Vanpool Program...

Continue Reading
Understanding Market Sentiments Surrounding XPO Logistics

Updated Category News Views 131

XPO's Short Interest Overview XPO's short percent of float has declined by 10.67% since the last report, with a current tally of 5.26 million shares sold short. This accounts for 5.19% of the overall shares available for trading. On average, it would take approximately 3.87 days for traders to cover their short positions based on the recent trading volumes. Importance of...

Continue Reading